Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hampe

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Gut|January 13, 2001
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel diseaseJ Hampe, N J Lynch, S Daniels, et al.
Annals of Human Genetics|August 28, 2003
Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex diseaseS A Fisher, A Moody, M M Mirza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Endocrine-Related Cancer|February 15, 2011
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer riskJ Sainz, A Rudolph, R Hein, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A mechanistic, model-based approach to safety assessment in clinical developmentJ Lippert, M Brosch, O von Kampen, et al.
Genes and Immunity|October 14, 2005
Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel diseaseW Zheng, P Rosenstiel, K Huse, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 6, 2003
Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel diseaseK King, A Moody, S A Fisher, et al.
Alimentary Pharmacology & Therapeutics|October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational studyA Stallmach, C Langbein, R Atreya, et al.
Zeitschrift Fur Gastroenterologie|July 14, 2015
[S2k Guideline non-alcoholic fatty liver disease]E Roeb, H M Steffen, H Bantel, et al.
American Journal of Human Genetics|December 1, 1999
Linkage of inflammatory bowel disease to human chromosome 6pJ Hampe, S H Shaw, R Saiz, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Gut|January 13, 2001
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel diseaseJ Hampe, N J Lynch, S Daniels, et al.
Annals of Human Genetics|August 28, 2003
Genetic variation at the chromosome 16 chemokine gene cluster: development of a strategy for association studies in complex diseaseS A Fisher, A Moody, M M Mirza, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Endocrine-Related Cancer|February 15, 2011
Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer riskJ Sainz, A Rudolph, R Hein, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
A mechanistic, model-based approach to safety assessment in clinical developmentJ Lippert, M Brosch, O von Kampen, et al.
Genes and Immunity|October 14, 2005
Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel diseaseW Zheng, P Rosenstiel, K Huse, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|June 6, 2003
Genetic variation in the IGSF6 gene and lack of association with inflammatory bowel diseaseK King, A Moody, S A Fisher, et al.
Alimentary Pharmacology & Therapeutics|October 8, 2016
Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational studyA Stallmach, C Langbein, R Atreya, et al.
Zeitschrift Fur Gastroenterologie|July 14, 2015
[S2k Guideline non-alcoholic fatty liver disease]E Roeb, H M Steffen, H Bantel, et al.
American Journal of Human Genetics|December 1, 1999
Linkage of inflammatory bowel disease to human chromosome 6pJ Hampe, S H Shaw, R Saiz, et al.
Pageof 7